Therapeutic Applications of Anti-Cancer Agents
A special issue of Bioengineering (ISSN 2306-5354).
Deadline for manuscript submissions: closed (31 January 2019) | Viewed by 147
Special Issue Editors
Interests: biomaterials; immunotherapy; drug delivery
Interests: localized drug activation; bio-orthogonal chemistry; soft-tissue sarcoma
Special Issue Information
Dear Colleagues,
The newest approaches to targeted anti-cancer therapies include identifying cancer specific molecules, disrupting cellular pathways, and localizing cytotoxic agents to the tumor environment. This paradigm shift reduces the risk of toxicity and enhances efficacy. This Special Issue will focus on two broad areas: (i) bio-orthogonal chemistry based approaches, and (ii) smart biomaterial-based approaches. We welcome experts in these areas of research to share their knowledge and further the discussion on next generation anti-cancer therapeutics.
Dr. Sangeetha Srinivasan
Dr. Jose M. Mejia Oneto
Prof. Dr. Glenn D. Prestwich
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- localized chemotherapy
- cancer treatment
- reduced toxicity
- bio-orthogonal chemistry
- copper-free click chemistry
- smart biomaterials
- nanoparticles
- targeted delivery
